ロード中...
Tumor and Endothelial Cell Hybrids Participate in Glioblastoma Vasculature
Background. Recently antiangiogenic therapy with bevacizumab has shown a high but transient efficacy in glioblastoma (GBM). Indeed, GBM is one of the most angiogenic human tumors and endothelial proliferation is a hallmark of the disease. We therefore hypothesized that tumor cells may participate in...
保存先:
| 主要な著者: | , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi Limited
2014-01-01
|
| シリーズ: | BioMed Research International |
| オンライン･アクセス: | http://dx.doi.org/10.1155/2014/827327 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|